SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,706,600 | -25.4% | 780,000 | 0.0% | 0.18% | -17.1% |
| Q2 2023 | $3,627,000 | -55.8% | 780,000 | -56.1% | 0.22% | -63.5% |
| Q1 2023 | $8,207,333 | -42.8% | 1,776,479 | 0.0% | 0.59% | -33.4% |
| Q4 2022 | $14,353,950 | +45.6% | 1,776,479 | 0.0% | 0.89% | +17.5% |
| Q3 2022 | $9,859,000 | +6.5% | 1,776,479 | 0.0% | 0.76% | -13.1% |
| Q2 2022 | $9,255,000 | -36.6% | 1,776,479 | 0.0% | 0.87% | -29.9% |
| Q1 2022 | $14,603,000 | – | 1,776,479 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |